» Articles » PMID: 35294586

A Functional Liver Imaging Score for Preoperative Prediction of Liver Failure After Hepatocellular Carcinoma Resection

Overview
Journal Eur Radiol
Specialty Radiology
Date 2022 Mar 16
PMID 35294586
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: Posthepatectomy liver failure (PHLF) is a challenging complication after resection to treat hepatocellular carcinoma (HCC), and it is associated with high mortality. Preoperative prediction of PHLF may improve patient subsequent and reduce such mortality. This study examined whether a functional liver imaging score (FLIS) based on preoperative gadoxetic acid-enhanced magnetic resonance imaging (MRI) could predict PHLF.

Materials And Methods: The study included 502 patients who underwent preoperative gadoxetic acid-enhanced MRI, followed by HCC resection. Significant preoperative predictors of PHLF were identified using logistic regression analysis. The ability of FLIS to predict PHLF was evaluated using receiver operating characteristic curves, and its predictive power was compared to that of the model for end-stage liver disease (MELD) score, albumin-bilirubin (ALBI) score, and indocyanine green 15-min retention rate (ICG-R15).

Results: In multivariate analysis, PHLF was independently associated with FLIS (OR 0.452, 95% CI 0.361 to 0.568, p < 0.001) and major resection (OR 1.898, 95% CI 1.057 to 3.408, p = 0.032). FLIS was associated with a higher area under the receiver operating characteristic curve (0.752) than the MELD score (0.557), ALBI score (0.609), or ICG-R15 (0.605) (all p < 0.05). Patients with FLIS ≤ 4 who underwent major resection were at 9.4-fold higher risk of PHLF than patients with lower FLIS who underwent minor resection.

Conclusion: FLIS is an independent predictor of PHLF, and it may perform better than the MELD score, ALBI score, and ICG-R15 clearance. We propose treating elevated FLIS and major resection as risk factors for PHLF.

Key Points: • A functional liver imaging score can independently predict posthepatectomy liver failure in patients with HCC. • The score may predict such failure better than MELD and ALBI scores and ICG-R15. • Patients with scores ≤ 4 who undergo major hepatic resection may be at nearly tenfold higher risk of posthepatectomy liver failure.

Citing Articles

Liver function estimation using multiphase hepatic CT: diagnostic performance of iodine-uptake and volumetric parameters.

Nagayama Y, Hokamura M, Taguchi N, Yokota Y, Osaki T, Ogasawara K Eur Radiol. 2025; .

PMID: 40080190 DOI: 10.1007/s00330-025-11497-1.


Application of ultrasound elastography and splenic size in predicting post-hepatectomy liver failure: Unveiling new clinical perspectives.

Xu S, Zhang T, He B, Liu J, Kong T, Zeng Q World J Gastroenterol. 2025; 31(4):98886.

PMID: 39877707 PMC: 11718641. DOI: 10.3748/wjg.v31.i4.98886.


Low functional liver imaging score is associated with poor prognosis following hepatectomy for hepatocellular carcinoma.

Sakai N, Takayashiki T, Takano S, Suzuki D, Ohtsuka M Sci Rep. 2024; 14(1):31290.

PMID: 39732922 PMC: 11682446. DOI: 10.1038/s41598-024-82741-9.


Advanced Imaging of Hepatocellular Carcinoma: A Review of Current and Novel Techniques.

Nguyen T, Vennatt J, Downs L, Surabhi V, Stanietzky N J Gastrointest Cancer. 2024; 55(4):1469-1484.

PMID: 39158837 DOI: 10.1007/s12029-024-01094-8.


Nomogram based on liver stiffness and spleen area with ultrasound for posthepatectomy liver failure: A multicenter study.

Cheng G, Fang Y, Xue L, Zhang Y, Xie X, Qiao X World J Gastroenterol. 2024; 30(27):3314-3325.

PMID: 39086747 PMC: 11287416. DOI: 10.3748/wjg.v30.i27.3314.


References
1.
Bray F, Ferlay J, Soerjomataram I, Siegel R, Torre L, Jemal A . Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018; 68(6):394-424. DOI: 10.3322/caac.21492. View

2.
Torre L, Bray F, Siegel R, Ferlay J, Lortet-Tieulent J, Jemal A . Global cancer statistics, 2012. CA Cancer J Clin. 2015; 65(2):87-108. DOI: 10.3322/caac.21262. View

3.
Forner A, Llovet J, Bruix J . Hepatocellular carcinoma. Lancet. 2012; 379(9822):1245-55. DOI: 10.1016/S0140-6736(11)61347-0. View

4.
Berzigotti A, Reig M, Abraldes J, Bosch J, Bruix J . Portal hypertension and the outcome of surgery for hepatocellular carcinoma in compensated cirrhosis: a systematic review and meta-analysis. Hepatology. 2014; 61(2):526-36. DOI: 10.1002/hep.27431. View

5.
Citterio D, Facciorusso A, Sposito C, Rota R, Bhoori S, Mazzaferro V . Hierarchic Interaction of Factors Associated With Liver Decompensation After Resection for Hepatocellular Carcinoma. JAMA Surg. 2016; 151(9):846-53. DOI: 10.1001/jamasurg.2016.1121. View